182 related articles for article (PubMed ID: 26408706)
1. Non-covalent Nanocomplexes of Folic Acid and Reducible Polyethylenimine for Survivin siRNA Delivery.
Zheng B; Yang S; Wang M; Yang X; Teng L; Xie J; Teng L; Lee RJ
Anticancer Res; 2015 Oct; 35(10):5433-41. PubMed ID: 26408706
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas.
Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK
Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518
[TBL] [Abstract][Full Text] [Related]
3. Targeted polyethylenimine/(p53 plasmid) nanocomplexes for potential antitumor applications.
Zhong Y; Wang Y; Luo L; Nurhidayah D; Maruf A; Gregersen H; Wu W; Wang GX
Nanotechnology; 2019 Apr; 30(14):145601. PubMed ID: 30524021
[TBL] [Abstract][Full Text] [Related]
4. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
Wang J; Dou B; Bao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
[TBL] [Abstract][Full Text] [Related]
5. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing.
Teo PY; Yang C; Whilding LM; Parente-Pereira AC; Maher J; George AJ; Hedrick JL; Yang YY; Ghaem-Maghami S
Adv Healthc Mater; 2015 Jun; 4(8):1180-9. PubMed ID: 25866054
[TBL] [Abstract][Full Text] [Related]
7. Folic acid modified cationic γ-cyclodextrin-oligoethylenimine star polymer with bioreducible disulfide linker for efficient targeted gene delivery.
Zhao F; Yin H; Zhang Z; Li J
Biomacromolecules; 2013 Feb; 14(2):476-84. PubMed ID: 23323627
[TBL] [Abstract][Full Text] [Related]
8. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine).
Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T
J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348
[TBL] [Abstract][Full Text] [Related]
9. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
[TBL] [Abstract][Full Text] [Related]
10. Non-covalent complexes of folic acid and oleic acid conjugated polyethylenimine: An efficient vehicle for antisense oligonucleotide delivery.
Yang S; Yang X; Liu Y; Zheng B; Meng L; Lee RJ; Xie J; Teng L
Colloids Surf B Biointerfaces; 2015 Nov; 135():274-282. PubMed ID: 26263216
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of murine breast cancer growth and metastasis by survivin-targeted siRNA using disulfide cross-linked linear PEI.
Liu S; Huang W; Jin MJ; Fan B; Xia GM; Gao ZG
Eur J Pharm Sci; 2016 Jan; 82():171-82. PubMed ID: 26554721
[TBL] [Abstract][Full Text] [Related]
12. Enhanced siRNA delivery using oleic acid derivative of polyethylenimine.
Teng L; Xie J; Teng L; Lee RJ
Anticancer Res; 2012 Apr; 32(4):1267-71. PubMed ID: 22493358
[TBL] [Abstract][Full Text] [Related]
13. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
Park K; Lee MY; Kim KS; Hahn SK
Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
[TBL] [Abstract][Full Text] [Related]
14. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS
Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582
[TBL] [Abstract][Full Text] [Related]
15. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis.
Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK
Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of Fe
Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
[TBL] [Abstract][Full Text] [Related]
17. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
[TBL] [Abstract][Full Text] [Related]
18. Targeted gene delivery mediated by folate-polyethylenimine-block-poly(ethylene glycol) with receptor selectivity.
Cheng H; Zhu JL; Zeng X; Jing Y; Zhang XZ; Zhuo RX
Bioconjug Chem; 2009 Mar; 20(3):481-7. PubMed ID: 19191579
[TBL] [Abstract][Full Text] [Related]
19. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
[TBL] [Abstract][Full Text] [Related]
20. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]